Opinion

Video

Advancing the State of Precision Medicine In Rheumatoid Arthritis

Author(s):

Nehad Soloman, MD, FACR,Andrew Sharobeem, DO, FACR

Expert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.

0:00 Introduction

01:29 Precision Medicine in Rheumatoid Arthritis (RA)

03:34 Biomarkers and Diagnostic Tools in RA

07:08 Science Behind Molecular Signature Response Classifier (MSRC) Test

08:30 Accelerate Information of Molecular Signatures (AIMS) Study

10:33 Experience with MSRC Test in Clinical Practice

12:46 Heterogeneity of RA and Development of Other Biomarkers in RA

14:49 MSRC Test Coverage by Medicare and Future of Precision Medicine in RA

17:54 Safe Step Act in RA Management and Success in Utilization of Precision Medicine

20:48 Final Thoughts and Recap of Discussion

Related Videos
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Psoriasis podcast
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
3 KOLs are featured in this series.
Related Content
Søren Andrea Just, MD, PhD, associate professor, University of Southern Denmark, and Odense University Hospital – Svendborg.
November 21st 2024

AI Assessments, Robotics Perform to Rheumatologist Levels in Joint Assessment

Victoria Johnson
Advancing the State of Precision Medicine in Rheumatoid Arthritis
November 17th 2023

Advancing the State of Precision Medicine in Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Vibeke Strand, MD, MACR, FACP
Hermine Brunner, MD, MDc, MBA, Director, Division of Rheumatology, and professor, Department of Pediatrics, Cincinnati Children’s
November 18th 2024

Tofacitinib Not Superior to Placebo in Systemic Juvenile Arthritis Double-Blind Trial

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Diane Lacaille, MDCM, MHSc, Scientific Director and Senior Scientist at Arthritis Research Canada and Professor, Department of Medicine, University of British Columbia, Vancouver.
November 15th 2024

Glucocorticosteroid Use for Rheumatoid Arthritis Increases CVD, Infection Mortality Risk Even After Cessation

Victoria Johnson
Karun Shrestha, MD, Internal Medicine Resident at St Barnabas Hospital and Research Fellow, Acute Care Research Consortium, Mayo Clinic
November 14th 2024

Study Finds Benefits and Risks in Cannabis Use for Rheumatoid Arthritis

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.